Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Rheumatoid Arthritis

  Free Subscription

Articles published in Clin Exp Immunol

Retrieve available abstracts of 15 articles:
HTML format

Single Articles

    September 2021
  1. TANG Y, Bai Z, Qi J, Lu Z, et al
    Altered peripheral B lymphocyte homeostasis and functions mediated by IL-27 via activating the mTOR signaling pathway in patients with rheumatoid arthritis.
    Clin Exp Immunol. 2021 Sep 24. doi: 10.1111/cei.13663.
    PubMed     Abstract available

    April 2021
  2. ISAILOVIC N, Ceribelli A, Cincinelli G, Vecellio M, et al
    Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis.
    Clin Exp Immunol. 2021 Apr 26. doi: 10.1111/cei.13609.
    PubMed     Abstract available

    March 2021
  3. OSADA A, Matsumoto I, Mikami N, Ohyama A, et al
    Citrullinated inter-alpha-trypsin inhibitor heavy chain 4 in arthritic joints and its potential effect in the neutrophil migration.
    Clin Exp Immunol. 2021;203:385-399.
    PubMed     Abstract available

  4. HALPERT G, Halperin Sheinfeld M, Monteran L, Sharif K, et al
    The tellurium-based immunomodulator, AS101 ameliorates adjuvant-induced arthritis in rats.
    Clin Exp Immunol. 2021;203:375-384.
    PubMed     Abstract available

    February 2021
  5. GLENNON-ALTY L, Moots RJ, Edwards SW, Wright HL, et al
    Type I interferon regulates cytokine-delayed neutrophil apoptosis, reactive oxygen species production and chemokine expression.
    Clin Exp Immunol. 2021;203:151-159.
    PubMed     Abstract available

    January 2021
  6. RINCON-AREVALO H, Rojas M, Vanegas-Garcia A, Munoz-Vahos C, et al
    Atypical phenotype and response of B cells in patients with seropositive rheumatoid arthritis.
    Clin Exp Immunol. 2021 Jan 18. doi: 10.1111/cei.13576.
    PubMed     Abstract available

    November 2020
  7. KHAN S, Longhurst H
    Epigenetic alterations on C1-inhibitor expression may influence hereditary angioedema attack frequency and C4 levels: Comment on: Karagianni P, Goules AV, Tzioufas AG. Epigenetic alterations in Sjogren's syndrome patient saliva.
    Clin Exp Immunol. 2020;202:144-145.
    PubMed     Abstract available

  8. KARAGIANNI P, Goules AV, Tzioufas AG
    Epigenetic alterations in Sjogren's syndrome patient saliva.
    Clin Exp Immunol. 2020;202:137-143.
    PubMed     Abstract available

    October 2020
  9. HALPERT G, Katz I, Shovman O, Tarasov S, et al
    IVIG ameliorate inflammation in collagen induced arthritis- projection for IVIG therapy in rheumatoid arthritis.
    Clin Exp Immunol. 2020 Oct 6. doi: 10.1111/cei.13532.
    PubMed     Abstract available

  10. WANG X, Sun L, He N, An Z, et al
    Increased expression of CXCL2 in ACPA-positive rheumatoid arthritis and its role in osteoclastogenesis.
    Clin Exp Immunol. 2020 Oct 3. doi: 10.1111/cei.13527.
    PubMed     Abstract available

    June 2020
  11. CANAVAN M, Marzaioli V, McGarry T, Bhargava V, et al
    Rheumatoid arthritis synovial microenvironment induces metabolic and functional adaptations in dendritic cells.
    Clin Exp Immunol. 2020 Jun 17. doi: 10.1111/cei.13479.
    PubMed     Abstract available

    April 2020
  12. LUBBERS R, Oostindie SC, Dijkstra DJ, Parren PWHI, et al
    Carbamylation reduces the capacity of IgG for hexamerization and complement activation.
    Clin Exp Immunol. 2020;200:1-11.
    PubMed     Abstract available

    January 2020
  13. DE BONT CM, Eerden N, Boelens WC, Pruijn GJM, et al
    Neutrophil proteases degrade autoepitopes of NET-associated proteins.
    Clin Exp Immunol. 2020;199:1-8.
    PubMed     Abstract available

    June 2019
  14. OI K, Tokunaga T, Kuranobu T, Yukawa K, et al
    Tumour necrosis factor alpha augments the inhibitory effects of CTLA-4-Ig on osteoclast generation from human monocytes via induction of CD80 expression.
    Clin Exp Immunol. 2019;196:392-402.
    PubMed     Abstract available

  15. HAGERT C, Siitonen R, Li XG, Liljenback H, et al
    Rapid spread of mannan to the immune system, skin and joints within 6 hours after local exposure.
    Clin Exp Immunol. 2019;196:383-391.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.